<DOC>
	<DOC>NCT03096522</DOC>
	<brief_summary>Patients with anal fistula who will undergo anal fistulotomy will be randomized into one of two groups; the first group will receive topical phenytoin therapy postoperatively and the second group will not receive such topical treatment.</brief_summary>
	<brief_title>Randomized Trial on the Effect of Topical Phenytoin on Healing After Fistulotomy</brief_title>
	<detailed_description>Patients with anal fistula who will undergo anal fistulotomy will be randomized into one of two groups; the first group will receive topical phenytoin therapy postoperatively and the second group will not receive such topical treatment. Healing of the wound after fistulotomy will be observed every week and the duration till complete healing will be recorded. The two groups will be compared regarding the mean duration till complete healing and postoperative complications.</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Rectal Fistula</mesh_term>
	<mesh_term>Phenytoin</mesh_term>
	<criteria>Patients of both genders aging between 1865 years with primary simple anal fistula (subcutaneous, intersphincteric, or low transsphicnteric involving less than 25% of external anal sphincter fibers) Patients with high transsphincteric, extrasphincteric, suprasphincteric, secondary, or recurrent anal fistulas. Patients with associated anorectal pathology such as anal fissure, hemorrhoids, rectal prolapse, neoplasm, solitary rectal ulcer, and inflammatory bowel diseases. Patients under chronic corticosteriod or immunosuppressive therapy.</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>